• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

择期冠状动脉造影和介入术前对比剂肾病风险的评分。

Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.

机构信息

Misericordia e Dolce Hospital, Prato, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2010 Jun;11(6):444-9. doi: 10.2459/JCM.0b013e328335227c.

DOI:10.2459/JCM.0b013e328335227c
PMID:20164783
Abstract

OBJECTIVES

To develop a simplified scoring system based on preprocedure clinical characteristics to predict contrast-induced nephropathy (CIN) before elective coronary angiography and percutaneous coronary intervention (PCI).

BACKGROUND

CIN is associated with increased mortality and morbidity following coronary angiography and PCI and accounts for increased hospital costs.

METHODS

Several baseline clinical characteristics of 1218 patients were considered as candidate univariate predictors of CIN (increase > or =0.5 mg/dl in serum creatinine within 5 days after contrast exposure). On the basis of the odds ratio at multivariate logistic regression, seven markers (with weighted scores) were identified as independent correlates of CIN: age at least 73 years (1), diabetes mellitus (2), left ventricular ejection fraction 45% or less (2), baseline serum creatinine value at least 1.5 mg/dl (2), baseline creatinine clearance 44 ml/min or less (2), posthydration creatinine > or = prehydration creatinine value (2) and one procedure effected within the past 72 h (3).

RESULTS

CIN occurred in 114 (9.4%) patients [range 1.1-52.1% for a low (< or =3) and very high (> or =9) risk score, respectively]; the odds of CIN increased significantly with each class (Cochran-Armitage chi-square, P < 0.0001) and the risk score allowed us to determine patients with low and high risk for postprocedure CIN (c-statistic = 0.86). These results were reproduced in a validation set.

CONCLUSION

Preprocedural clinical risk factors have different influences on the likelihood of CIN. Risk classification based on the most significant parameters can be used to predict CIN before contrast exposure. The simple scoring system proposed here provides a good estimate of the risk of CIN, allowing the interventional team to make adequate adjustment to the procedures.

摘要

目的

建立一种基于术前临床特征的简化评分系统,用于预测择期冠状动脉造影及经皮冠状动脉介入治疗(PCI)前的对比剂肾病(CIN)。

背景

CIN 与冠状动脉造影及 PCI 后死亡率和发病率增加相关,并导致住院费用增加。

方法

考虑了 1218 例患者的几种基线临床特征,这些特征是 CIN 的候选单变量预测因子(造影剂暴露后 5 天内血清肌酐升高>或=0.5mg/dl)。基于多变量逻辑回归的比值比,确定了 7 个标志物(带有权重评分)为 CIN 的独立相关因素:年龄≥73 岁(1)、糖尿病(2)、左心室射血分数 45%或更低(2)、基线血清肌酐值≥1.5mg/dl(2)、基线肌酐清除率 44ml/min 或更低(2)、水化后肌酐值≥水化前肌酐值(2)以及在过去 72h 内进行 1 次手术(3)。

结果

114 例(9.4%)患者发生 CIN[低值(<或=3)和极高值(>或=9)风险评分组分别为 1.1%-52.1%];CIN 风险随着评分级别的增加而显著增加(Cochran-Armitage 卡方检验,P<0.0001),风险评分可确定术后发生 CIN 的低危和高危患者(C 统计量=0.86)。这些结果在验证组中得到了复制。

结论

术前临床危险因素对 CIN 的发生概率有不同的影响。基于最显著参数的风险分类可用于预测造影剂暴露前的 CIN。这里提出的简单评分系统可以很好地估计 CIN 的风险,使介入团队能够对手术进行适当的调整。

相似文献

1
Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.择期冠状动脉造影和介入术前对比剂肾病风险的评分。
J Cardiovasc Med (Hagerstown). 2010 Jun;11(6):444-9. doi: 10.2459/JCM.0b013e328335227c.
2
A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention.经皮冠状动脉介入治疗后对比剂诱导急性肾损伤的简单术前评分。
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E8-16. doi: 10.1002/ccd.25109. Epub 2013 Sep 30.
3
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.经皮冠状动脉介入治疗后预测对比剂肾病的简单风险评分:开发与初步验证
J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9. doi: 10.1016/j.jacc.2004.06.068.
4
Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure.使用非离子等渗对比剂进行冠状动脉介入术后对比剂肾病对心脏结局的影响。
J Cardiol. 2010 Nov;56(3):300-6. doi: 10.1016/j.jjcc.2010.07.002. Epub 2010 Aug 13.
5
Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.术前N末端脑钠肽前体(NT-proBNP)在预测择期冠状动脉造影术后的造影剂诱导的肾病(CIN)方面与梅兰造影剂诱导的肾病(CIN)评分相似。
J Am Heart Assoc. 2015 Apr 17;4(4):e001410. doi: 10.1161/JAHA.114.001410.
6
Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes.糖尿病患者冠状动脉造影或经皮冠状动脉介入术后对比剂肾病的药物疗效及临床研究
Am J Ther. 2017 Jul/Aug;24(4):e423-e430. doi: 10.1097/MJT.0000000000000325.
7
A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.一项关于碘克沙醇与碘普罗胺在接受冠状动脉造影(无论是否进行经皮冠状动脉介入治疗)的慢性肾脏病患者中的疗效及心肾安全性的前瞻性、双盲、随机对照试验。
Catheter Cardiovasc Interv. 2008 Dec 1;72(7):958-65. doi: 10.1002/ccd.21713.
8
Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.择期行心脏导管插入术或经皮冠状动脉介入治疗的糖尿病患者对比剂肾病的预测:容量与肌酐清除率比值及碘剂量与肌酐清除率比值的作用
J Med Assoc Thai. 2010 Jan;93 Suppl 1:S29-34.
9
Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.接受经皮冠状动脉介入治疗患者中对比剂肾病的临床结局:一项分析水化和乙酰半胱氨酸作用的前瞻性、多中心、随机研究
Int J Cardiol. 2008 Jun 6;126(3):407-13. doi: 10.1016/j.ijcard.2007.05.004. Epub 2007 Jul 24.
10
Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.用于预测经皮冠状动脉介入治疗中存在预先存在的肾功能损害患者对比剂诱导肾病的风险评分系统。
Singapore Med J. 2012 Mar;53(3):164-9.

引用本文的文献

1
CCTA-Guided Selective Invasive Coronary Catheterization: A Strategy to Reduce Contrast Volume and Improve Efficiency.冠状动脉CT血管造影(CCTA)引导下的选择性侵入性冠状动脉导管插入术:一种减少造影剂用量并提高效率的策略。
Diagnostics (Basel). 2025 Apr 1;15(7):890. doi: 10.3390/diagnostics15070890.
2
Association Between IV Contrast Media Exposure and Acute Kidney Injury in Patients Requiring Emergency Admission: A Nationwide Observational Study in Japan.静脉造影剂暴露与急诊入院患者急性肾损伤的关联:日本全国观察性研究。
Crit Care Explor. 2024 Aug 26;6(9):e1142. doi: 10.1097/CCE.0000000000001142. eCollection 2024 Sep 1.
3
Clinical Outcomes for Acute Kidney Injury in Acute Myocardial Infarction Patients after Intra-Aortic Balloon Pump Implantation: A Single-Center Observational Study.
急性心肌梗死患者主动脉内球囊反搏植入术后急性肾损伤的临床结局:一项单中心观察性研究
Rev Cardiovasc Med. 2023 Jun 12;24(6):172. doi: 10.31083/j.rcm2406172. eCollection 2023 Jun.
4
Contrast-Induced Nephropathy in Interventional Cardiology: Incidence, Risk Factors, and Identification of High-Risk Patients.介入心脏病学中的对比剂肾病:发病率、危险因素及高危患者的识别
Cureus. 2023 Dec 29;15(12):e51283. doi: 10.7759/cureus.51283. eCollection 2023 Dec.
5
Diagnostic efficacy of the triglyceride-glucose index in the prediction of contrast-induced nephropathy following percutaneous coronary intervention.三酰甘油-葡萄糖指数对经皮冠状动脉介入治疗后造影剂肾病预测的诊断效能。
Front Endocrinol (Lausanne). 2023 Nov 22;14:1282675. doi: 10.3389/fendo.2023.1282675. eCollection 2023.
6
Comparison of the Performance of the NCDR CathPCI Score and Mehran Score to Predict Acute Kidney Injury Post-Percutaneous Coronary Intervention.比较NCDR CathPCI评分与梅兰评分预测经皮冠状动脉介入治疗后急性肾损伤的性能。
HCA Healthc J Med. 2020 Oct 29;1(5):305-314. doi: 10.36518/2689-0216.1110. eCollection 2020.
7
Different hydration methods for the prevention of contrast-induced nephropathy in patients with elective percutaneous coronary intervention: a retrospective study.不同水化方法预防择期经皮冠状动脉介入治疗患者对比剂肾病的回顾性研究。
BMC Cardiovasc Disord. 2023 Jun 24;23(1):323. doi: 10.1186/s12872-023-03358-w.
8
Contrast-induced acute kidney injury and its contemporary prevention.对比剂所致急性肾损伤及其现代预防措施
Front Cardiovasc Med. 2022 Dec 6;9:1073072. doi: 10.3389/fcvm.2022.1073072. eCollection 2022.
9
Ultra-low CONtraSt PCI vs conVEntional PCI in patients of ACS with increased risk of CI-AKI (CONSaVE-AKI).超高对比剂 PCI 与常规 PCI 在有 CI-AKI(CONSaVE-AKI)风险增加的 ACS 患者中的比较。
Indian Heart J. 2022 Sep-Oct;74(5):363-368. doi: 10.1016/j.ihj.2022.08.004. Epub 2022 Aug 22.
10
Contrast-Associated Acute Kidney Injury: Advances and Challenges.造影剂相关急性肾损伤:进展与挑战
Int J Gen Med. 2022 Feb 15;15:1537-1546. doi: 10.2147/IJGM.S341072. eCollection 2022.